Risk factors and consequences of persistent type II endoleaks Ruby C. Lo, MD, Dominique B. Buck, MD, Jeremy Herrmann, BA, Allen D. Hamdan, MD, Mark Wyers, MD, Virendra I. Patel, MD, Mark Fillinger, MD, Marc L. Schermerhorn, MD Journal of Vascular Surgery Volume 63, Issue 4, Pages 895-901 (April 2016) DOI: 10.1016/j.jvs.2015.10.088 Copyright © 2016 Society for Vascular Surgery Terms and Conditions
Fig 1 Consort diagram of inclusion and exclusion criteria for this study. EVAR, Endovascular aneurysm repair. Journal of Vascular Surgery 2016 63, 895-901DOI: (10.1016/j.jvs.2015.10.088) Copyright © 2016 Society for Vascular Surgery Terms and Conditions
Fig 2 Freedom from reinterventions among patients with no/transient type II endoleaks (T2Es) vs patients with persistent/new type II endoleaks. Journal of Vascular Surgery 2016 63, 895-901DOI: (10.1016/j.jvs.2015.10.088) Copyright © 2016 Society for Vascular Surgery Terms and Conditions
Fig 3 Survival of patients with no/transient type II endoleaks vs patients with persistent/new type II endoleaks. Journal of Vascular Surgery 2016 63, 895-901DOI: (10.1016/j.jvs.2015.10.088) Copyright © 2016 Society for Vascular Surgery Terms and Conditions